Honcharenko DО. New ApproacheThe pharmaceutical industry’s R&D expenditure at the global level in 2007–2018 is analyzed. Two-thirds of the global pharmaceutical companies’ spending on R&D are accounted for s to the Assessment of Foreign Trade in High-Tech Pharmaceuticals. Stat. Ukr. [Internet]. 2020 Mar. 1 [cited 2026 Mar. 21];88(1):35-41. Available from: https://su-journal.com.ua/index.php/journal/article/view/281